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ABSTRACT
A DEEP LEARNING APPROACH TO DETECT DIABETIC RETINOPATHY IN FUNDUS IMAGES
Winston Furtado
April 2019
Background: Diabetic retinopathy is a disease caused due by complications of diabetes mellitus
which can lead to blindness. About 33% of the US population with diabetes also show symptoms
for diabetes retinopathy. If not treated, diabetic retinopathy worsens over time by progressing
through two main pathological stages of non-proliferative and proliferative and four clinical
stages. While the diagnostic accuracy of detecting diabetic retinopathy through machine learning
have shown to be successful for OCT images, the accuracy of ultra-widefield fundus images
have yet to be fully reported. This paper describes a method to non-invasively detect and
diagnose diabetic retinopathy from ultra-widefield fundus images.
Methods: A total of 62 graded-images were obtained from the Cleveland Clinic. A deep learning
algorithm was developed to identify and extract features from the images. The algorithm was
then simulated to classify the test images into one of three clinical classes. Data was collected on
the accuracy and probability of the diagnosis/classification.
Results: The classification algorithm had an average accuracy that ranged from 92% to 97% for
the training images and 50% for the test images. Confusion matrices were created to obtain
statistical measures of performance such as sensitivity, false negative rate, precision, and the
false discovery rate. The sensitivity decreased from 70% to 50% as the image size increased. The
precision also decreased from 65% to 50% as the image size increased. Validation methods such
as image normalization and transfer learning showed no improvement in classification accuracy.
Conclusion: This study demonstrates the potential for applying deep learning algorithms to
classify ultra-widefield images. This study also demonstrates the need for doctors to further
examine the diagnosis to account for false positives and/or misdiagnosis. Additionally,
limitations and their impact on the simulation of the deep learning algorithm were explored.
Keywords: diabetic retinopathy; deep learning; CNN; image classification; ultra-wide field imaging
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I. INTRODUCTION
Diabetic retinopathy (DR) is the leading cause of blindness among adults in
the United States. It is the result of diabetes mellitus which itself is a global epidemic
leading to a range of complications [1]. The main risk factors associated with diabetic
retinopathy are duration of the diabetes, high blood sugar levels, and arterial
hypertension [2][3][4]. At the onset, it affects the blood vessels in the retina, a
photosensitive tissue found at the back of the eye. Overtime, under high elevation of
glucose, the blood vessels can cause capillary endothelial damage which results in the
cells along the capillary to become “leaky”. The high glucose levels combined with
endothelial damage lead to capillary occlusion which, in turn, leads to reduced blood
flow [5]. If not treated, diabetic retinopathy progresses through four clinical stages
(Figure 1) of mild non-proliferative, moderate non-proliferative, severe nonproliferative, which is sometimes subclassified into severe non-proliferative and very
severe non-proliferative, and proliferative which is sometimes subclassified into nonhigh risk proliferative, and high risk proliferative, and advanced proliferative. In each
stage there are problems that can occur (shown in Figure 2): such as microaneurysms
(mild, moderate, severe, and proliferative stages), hemorrhages (moderate, severe, and
proliferative stages), exudates (moderate, severe and proliferative stages), cotton-wool
spots (severe, pre-proliferative, and proliferative stages), and intraretinal
microvascular anomalies (proliferative stage) [5]. Microaneurysms are one of the
earliest signs of diabetic retinopathy; classified as mild non-proliferative. They appear
as red dots in the retina due to an expansion of the capillaries. In small numbers,
microaneurysms do not affect the eyesight of a patient. Regardless, the number of
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microaneurysms can be used to estimate the regression or progression of diabetic
retinopathy. Hemorrhages occur due to the rupture of small blood vessels in the retina,
which results in red lesions. Hemorrhages occur deep in the retina where their shape is
determined by their location or position. Even though hemorrhages are a cause of
concern, they do not functionally disrupt the eye. Like microaneurysms, the number of
hemorrhages can be used to estimate the progression or regression of diabetic
retinopathy. Exudates define the yellow-white lesions that occur due to the leakage of
plasma from capillaries near the macular region. Exudates away from the macular
region have been observed but have not been found to cause serious problems. The
first sighting of exudates means that diabetic retinopathy has progressed from the mild
to the moderate non-proliferative stage. Cotton-wool spots are caused by failure of
capillary circulation, which leads to the swelling of nerve fibers. They appear as pale
or fuzzy areas on the retina. Solely, the cotton-wool spots do not cause visual
problems, but their presence is graded as pre-proliferative or severe depending on how
widespread they are. Intraretinal microvascular anomalies (IRMAs) or microvascular
abnormalities represent the first sign of new blood vessels appearing. The cause of
IRMAs is due to the dilation of capillaries and the shunts between the arteries and
veins. Additionally, the retinal veins appear tortuous and irregular. Any patient with
IRMAs is classified as proliferative, in which case they must seek medical help
immediately.

It is estimated that about 30% to 50% of the diabetic population has
retinopathy. In longitudinal studies, about 30% of the affected individuals showed
symptoms of diabetic retinopathy after 10 to 20 years of progression with diabetes
2

mellitus. Of the 30% affected, 10% progressed to proliferative retinopathy, which puts
patients at risk of blindness. In 90% of the cases examined, non-proliferative
retinopathy is responsible for a serious loss of visual capacity. Non-proliferative
retinopathy is also observed to occur more often in cases where diabetes onset started
in adulthood, whereas proliferative retinopathy is present “generally”, though not
always in juvenile forms of the disease [5]. Another study, the classical Wisconsin
Epidemiologic Study of Diabetic Retinopathy (WESDR), reported that about 75% of
people diagnosed with diabetes mellitus showed signs and symptoms of diabetic
retinopathy after 10 years. For those who developed early symptoms, about 66% of
the people exhibited the severe stage of diabetic retinopathy. About 20% of those
affected had the disease progress to proliferative diabetic retinopathy or diabetic
macular odema, a subtype of diabetic retinopathy that involves the macula
[2][3][6][7].

Before 1961, to detect diabetic retinopathy, various diagnostic techniques were
utilized. A visual acuity test was used to detect how well a person could see at various
distances. A dilated eye exam was done to closely examine the retina and optic nerve
for signs of damage. Additionally, a tonometry was done to detect abnormal pressure
(<12 mmHg or >22 mmHg) inside the eye [8]. With the advance of diagnostic
medicine came the arrival of new imaging technologies. One such technology was
fluorescein angiography. Fluorescein angiography involved using a fluorescent dye to
mark the eye after which pictures were taken to identify vascular leakage and the
presence of ischemia [9] [10]. Although traditionally used as the primary method in
diagnosing diabetic retinopathy, fluorescein angiography was phased out over time in
3

Figure 1 - Stages of diabetic retinopathy [31].
preference of optical coherence tomography (OCT). Optical coherence tomography
was considered a major technical innovation that did not require the need for pupil
dilation and could be adopted with telemedicine to offer fast, accurate, systematic
solutions in both developed and developing countries. [11] [12] [13]. As a noninvasive diagnostic technology, it creates high-resolution images of the retina to
record 3D structural changes (e.g. odema) which otherwise cannot be deduced through
a clinical examination of retinal pictures. At present, new fundus photography
techniques are being tested and developed (e.g. wide-field fluorescein angiography)
with some already introduced to the market, including the ultra-widefield (UWF)
retinal imaging device, Optos 200 Tx, sold by Optos plc. Compared to current
imaging techniques, ultra-widefield devices can image up to 200 degrees, thus
providing more information to help clinicians accurately diagnose the condition.
Additionally, these devices have a shorter image processing time and allow for image
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Figure 2 – Representations of various types of damage to capillaries in DR. (a)
normal capillary. (b) microaneurysm. (c) hemorrhage. (d) exudate [5].
5

duplication and manipulation with ease [32].
With a recent rise in machine learning, applications in medical diagnostics
have been explored due to their high classification accuracy. Deep learning, a subset
of machine learning, uses multiple layers for feature extraction from an image. The
input into each layer uses the output from the previous layer thus allowing every layer
in the algorithm to independently learn the features. Deep learning models are
typically trained using large datasets with an appropriate neural network to learn the
features in an image without prior knowledge. The use of deep learning for medical
images has been studied by LeCun et al. [14], Liu et al. [15], and Litjens et al. [16].
While most of the research on optical coherence tomography images has been
explicitly based on segmenting features such as blood vessels and identifying the
stage of diabetic retinopathy through a classifier, new research in the ophthalmologic
field has been done by Pratt et al. [17], Sangeethaa et al. [18], and Chandrakumar [19]
to detect diabetic retinopathy using the convoluted neural network (CNN). This
network consists of three layers: input layer, hidden layer, and output layer. The
hidden layer encompasses convolution and pooling layers to reduce computational
time. As a part of deep learning, CNNs eliminate the need for manual feature
extraction and can be retrained for new classification tasks. While the diagnostic
accuracy of detecting diabetic retinopathy from OCT images has proven to be
successful through CNN, the accuracy of ultra-widefield fundus images have yet to be
fully investigated, especially involving various classes/stages. Therefore, the goals of
this study are to develop and utilize CNN to help classify ultra-widefield fundus
images into one of the 3 major classes of diabetic retinopathy; evaluate and compare
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the accuracy of the classification between different areas and sizes of fundus images;
and explore the limitations of using CNN for ultra-widefield images.
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II. METHODS
2.1 Image Dataset
The images for this research were received from the Cleveland Clinic. There
was a total of 62 images sent, 26 TIF format and 36 JPEG format, each of which
represented 62 patients. The images were taken by a technician on an ultra-wide field
ophthalmoscope with the resulting dimensions of most images being 3900 × 3071
(JPEG) and the remaining images being 3900 × 3072 (TIF). The horizontal and
vertical resolution was 96 dpi (dots per inch). These images were then graded by an
ophthalmologist and categorized into 1 of 7 classes based on the Early Treatment
Diabetic Retinopathy Study (ETDRS) scale: mild (11 images), moderate (11 images),
severe (15 images), very severe (14 images), non-high risk (4 images), high risk (3
images), and advanced (4 images).

2.2 Preparation and Pre-processing of Images
Due to the small number of images and uneven classes, the fundus images
were organized into three main classes: mild (mild + moderate images), severe (severe
+ very severe images), and high risk (non-high risk + high risk + advanced images).
This was done to balance the classes and provide enough training data for the machine
learning algorithm. It is important to note that if there were “normal” images or
images that showed no signs of diabetic retinopathy, then four classes would’ve been
created to differentiate between normal, mild, severe, and high-risk diabetic
retinopathy. Once the images were organized, using MATLAB, five masks at various
diameters following a concentric pattern from the center of the fundus image were
created. The masks were created to help isolate the region of interest (ROI) in the
8

fundus images. After the creation of the mask, desired images with the ROI were cut
out and converted to TIF format to prepare for training through the CNN. To begin
pre-processing, the desired image dimension (e.g. 32 × 32) was chosen for the input
layer. Once the images were inputted, they were shuffled to make MATLAB re-train
with new images for each new training session. Then, image augmentation was
utilized to randomly rotate and reflect the images to prevent overfitting and
memorization of image features due to the small size of the image dataset.

2.3 Neural Network Design
A CNN was developed to classify fundus images into 3 classes. This network
consists of a 2D convolution layer, batch normalization layer, rectified linear unit
(ReLU) layer, max pooling layer, fully connected layer, softmax layer, and
classification layer (Figure 3).

Figure 3 – Neural network schematic.
First, a 2D convolution layer was deployed, consisting of 5 filters with a stride
(step size in which the filter moves) of 1, which convolved the input layer by applying
sliding filters horizontally and vertically. Given that the input pixel value of each
fundus image examined is x(a,b,c), the output of the convolutional layer is y(w,y,z) 9

which represents the feature maps extracted by convolving x(a,b,c) with f(w,a,b,c) - is
specified as follows:
𝑦(𝑤, 𝑦, 𝑧) = ∑5𝑎=1 ∑5𝑏=1 ∑3𝑐=1 𝑓(𝑤, 𝑎, 𝑏, 𝑐) ∙ 𝑥(𝑎 + 𝑦 − 1, 𝑏 + 𝑧 − 1, 𝑐) + 𝑏(𝑤)

(1)

w represents the filter index where w = 1,2,3,4, 5. Similarly, m = 1,2,3,4…q and n =
1,2,3,4…q where q represents the input dimension of the image. The terms b(w) and
f(w,a,b,c) represent the biases and weights of the filters, respectively [20]. Due to the
small dataset and to avoid underfitting, the bias values and weights were kept at default
values. The weights were initialized with the Glorot initializer, which is optimal for
neural networks with a single hidden layer, with a small Gaussian value with zero mean
and variance = 2/(fan-in + fan-out) where fan-in = filterSize1× filterSize2 × Number of
Input Channels and fan-out = filterSize1× filterSize2 × Number of Hidden Channels. The
bias values were initialized with zeros since symmetry-breaking is provided through the
weights. The number of neurons in a convolution layer is equivalent to the Map Size ×
Number of Filters. For example, if the input image is 32-by-32-by-3 the map size would
be 15-by-15 since (32-5+(1×1))/2 +1 ≈ 15. The Map Size is then multiplied by the
Number of Filters resulting in the total number of neurons being 15 × 15 × 5 = 1125.
After the output was obtained, a batch normalization layer was included after each
convolution layer, normalizing the input and speeding up training while reducing the
sensitivity to network initialization. As shown in equation (2), the layer functions by
calculating the normalized activations by using the mean μB and σ2B over the input
channel and the mini batch. If the variance is very small, the ε property comes into play
by improving the numerical stability [21].
10

(2)

The batch normalization layer was then followed by the rectified linear unit (ReLU)
layer. This layer sets any value less than zero to zero; a type of threshold operation
equivalent to equation (3) [22].
(3)

A max pooling layer was implemented to perform down sampling by separating
the input into “rectangular pooling regions and computing the maximum of each region”;
specifically, a pooling layer with 2 filters and a stride of 2 [23]. Next, the fully connected
layer was deployed to acquire sub-feature maps to help classify them into three classes.
The outputSize was set to 3 which represented the three classes: mild, severe, and high
risk. The fully connected layer functioned by multiplying the input by a weight matrix
and then adding a bias to that matrix as shown in equation (4) [24] [25] [26]:
32
𝑓(𝑡) = ∑4𝑘=1 ∑32
̅(𝑙, 𝑚, 𝑛) ∙ 𝑔(𝑙, 𝑚, 𝑛) + 𝑏̅(𝑡)
𝑗=1 ∑𝑖=1 𝑤

(4)

The terms 𝑤
̅(𝑙, 𝑚, 𝑛) and 𝑏̅(𝑡) represent the weights and bias; t is the index where t = 1,
2, and 3. As mentioned before, no bias values or weights were specified to avoid
underfitting. Following the fully connected layer was the softmax function, which
calculates the probability distribution. The softmax function is also known as the
normalized exponential function and is defined as such for multi-class classification
problems:
11

P(dr |y, θ) =

P( y,θ | dr )P(dr )
∑𝑚
𝑖=1 P( y,θ | dj )P(dj )

=

𝑒 (𝑏𝑟(𝑦,𝜃))

(5)

(𝑏𝑗 (𝑦,𝜃))
∑𝑚
𝑖=1 𝑒

The limits for the probability, P(dr |y, θ), are from 0 to 1 and the term ∑𝑚
𝑖=1 𝑃( 𝑑𝑗 | 𝑦, 𝜃) is
equal to 1. Additionally, br = ln(𝑃( 𝑦, 𝜃 | 𝑑𝑟 )𝑃(𝑑𝑟 )) where 𝑃( 𝑦, 𝜃 | 𝑑𝑟 ) is the conditional
probability of the sample class r and the prior probability P(dr) [27] . To successfully
classify each fundus image, the cross-entropy loss was calculated in the final layer called
the classification layer. The cross-entropy loss is defined as such:

𝐻
Loss = − ∑𝑀
𝑗=1 ∑𝑖=1 𝑠𝑗𝑖 ln 𝑢𝑗𝑖

(6)

H is the number of classes, M is the number of samples, sji is the indicator that
correlates the jth sample to the ith class, and uji is the output of the softmax function,
associating the jth input with the ith class [27].

2.4 Simulation Options
Once the neural network was designed, the simulation options were specified.
The learn rate of 0.01 was specified along with the maximum number of epochs of
100 and a mini-batch size of 48. For network training, 52 randomly selected images
were used. The remaining images (10) were used for classification. The command
shuffle every-epoch was used to shuffle the training data before each epoch and also to
take advantage of the batch normalization effect, thus making the training of the

12

neural network an effortless optimization problem. The algorithm used for training is
the stochastic gradient descent with momentum (SGDM), which is defined as

θn+1 = θn - β∇F(θn) + η(θn – θn-1)

(7)

where θ is the parameter vector n is the iteration number, β is the learn rate (β>0),
η(θn– θn-1) is the momentum term/parameter, and F(θ) is the loss function. This
SGDM algorithm minimizes the cross-entropy loss across the mini-batch by
proceeding incrementally at each iteration in the direction of the gradient loss. Adding
the momentum term, value of 0.9, helps reduce oscillations along the path of steep
descent toward the optimum value [28].
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III. DISCUSSION
3.1 Results
The neural network was simulated for a total of 25 times with 5 trials for each
image size: 32×32, 64×64, 128×128, 256×256, and 512×512. The average
simulation/processing time ranged from 25 seconds for 32×32 images, to 22 minutes for
512×512 images. A confusion matrix was created for each of the image sizes to obtain
statistical measures of performance, such as sensitivity, false negative rate, precision, and
the false discovery rate. The sensitivity was 70% for 32×32 images, 65% for 64×64
images, 60% for 128×128 images, 50% for 256×256 images and 50% for 512×512
images. The sensitivity decreased as the size of the images increased; the opposite is true
for the false negative rate. Similarly, the precision was 65% for 32×32 images, 65% for
64×64 images, 60% for 128×128 images, 50% for 256×256 images, and 50% for
512×512 images. The precision decreased as the size of the images increased, while the
false discovery rate increased as the size of the images increased (Appendix II). These
statistical measures suggest that a combination of a small image dataset and uneven
classes may contribute to an increase in type I and type II errors thus leading to irrelevant
results. The classification accuracy of the training and the test sets was determined by
adding the number of correctly classified images divided by the total number of classified
images; 52 images total for training and 10 images total for testing. As shown in Table 1,
the training accuracy for the 32×32, 64×64, and 128×128 images ranged from 92% to
97%. For both the 256×256 and 512×512 images, the training accuracy was 46%. The
training accuracy represents the accuracy of the neural network model on the image sets
on which it was constructed. While within 100 epochs, most of the images up to size of
14

128×128 approached >90% training accuracy, the images of sizes 256×256 and 512×512
had their respective training accuracy plateau at 46% with the 45th iteration (or epoch).

Table 1 – Average classification accuracy of training and test images for 5 trials

Image Sizes

Avg. Training Accuracy (%) Avg. Test Accuracy (%)

32×32

92.692

50.000

64×64

97.307

48.000

128×128

96.923

52.000

256×256

46.153

50.000

512×512

46.538

50.000

The plateauing of the accuracy is significant because it means that the algorithm has hit
convergence, where further training is likely to degrade the test accuracy and the training
accuracy and result in overfitting. The test accuracy is the accuracy of the images the
model has yet to see. Although the test accuracy of all the images was around 50%, an
important observation to note is that the test accuracy did not improve as the image size
increased, as one would intuitively believe since larger images have more pixel data. This
shows, as is commonly known in the ophthalmologic field, that the majority (~90%) of
cases, the information for proper diagnosis is around the optic nerve and macula region of
the eye. Moreover, this suggests that different ROIs do not impact the diagnosis of DR.

3.2 Validation
While the accuracy results were not ideal, they provide some insight into why
they are low. Noticing the discrepancy between training accuracy and test accuracy, one
would think that overfitting might be the reason. So, to test this hypothesis and to verify
15

the results, two methods were used: image normalization and transfer learning.
Image normalization is the process of changing the histogram values of an image
to bring it to a range of intensity values that is “normal” (normal distribution). This
avoids the influence of very low and very high noise in the image. In machine learning,
image normalization is sometimes used to make learning more stable and to make the
neural network generalize favorably to unseen data by reducing the variability between
the training set and the testing set [18]. For this simulation, all images were normalized
by taking each individual color channel and dividing them by the magnitude of all three
(RGB) color channels (Figure 4).

Figure 4 – Normalized fundus image.

After normalization, the images were trained and tested using the CNN algorithm and
produced the following results (Table 2):
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Table 2 – Average classification accuracy of normalized images for 5 trials

Image Sizes

Avg. Training Accuracy (%)

Avg. Test Accuracy (%)

32×32

88.461

50.000

64×64

96.153

50.000

128×128

94.423

50.000

256×256

46.153

50.000

512×512

46.153

50.000

The results show a similar pattern to the original results where the training accuracy is
relatively high for image sizes of 32×32, 64×64, and 128×128 followed by a steep
decrease to 46% for image sizes of 256×256 and 512×512. The test accuracy did not
show a significant difference from the original results, staying around 50%. Two things
that can be concluded from this method is that overfitting is not a cause for the
discrepancy in the accuracy values and that the varied levels of lighting in the original
images, which could possibly affect pixel intensity values and create unnecessary
variation, did not impact the test accuracy.
Transfer learning utilizes a model that has been trained on a larger dataset which
can be fine-tuned for a new task or new dataset; especially small datasets (<1000
images). Compared to the performance of a model that is trained from scratch, it achieves
higher network performance in a short amount of time. The pre-trained model used for
transfer learning for this study is called AlexNet. This model was developed by Alex
Krizhevsky utilizing the CNN algorithm. It has been trained on 1.2 million images from
the ImageNet Dataset (http://image-net.org/index) with image dimensions of 227×227.
The structure of the model consists of 5 convolution layers which together with the
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remaining layers add to a total of 23 [29]. Once the model is selected, the last
classification layer is replaced for a new classification task. Since an image size of
227×227 is required as the input, fundus images with dimensions of 256×256 and
512×512 were used by utilizing the function augmentedImageDatastore to automatically
resize the images with no loss of data. Then, the model was simulated, and the training
accuracy and test accuracy were obtained. Similar to the results of the normalized images
and the original results, after 5 trials the average test accuracy was found to be 50%. On
the other hand, the training accuracy was 100%. The high training accuracy is most likely
due to overfitting since the transfer learning model did not include an image
augmentation step to account for overfitting. While the use of transfer learning to
improve classification of DR has been done using AlexNet [30], in this case transfer
learning showed no significant improvement compared to the original method that was
done from scratch. This strongly suggests that any additional convolution layers are
unnecessary since the algorithm has already extracted all the features with one
convolution layer for successful classification.
3.3 Limitations
The reason that neither the original method nor the validation methods were able
to achieve greater than 50% accuracy can be attributed to one of many reasons which are
also the limitations of this study. One limitation, perhaps the most impactful limitation,
was the small amount of data available. While researchers have been able to use a small
dataset to detect DR from 140 OCT images with a classification accuracy of 93%, no
current literature exists demonstrating this with ultra-widefield fundus images. One could
argue that with a more complex algorithm, i.e. with additional convolution layers, one
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could achieve better performance [18]. However, as stated previously that even with
additional layers, the algorithm showed no improvement in performance.
Another limitation was the unbalanced image classes caused by a lack of diseased
images. Initially, the images were rearranged into four classes where the classification
accuracy (test accuracy) was found to be 35%. With the images rearranged into 2 classes,
the classification accuracy was 60% (see Appendix III for probability values). Although
decreasing the number of classes does increase accuracy, it is not beneficial for doctors
since they would need to further examine the fundus images to determine the best
treatment plan. Other ways to tackle the unbalanced image classes were to balance the
classes by removing images from larger classes or by adjusting weights and bias
components in the algorithm. By having an equal number of images in each of the three
classes, the training accuracy decreased to around 80% for most of the image sizes and
the test accuracy decreased for three of the image sizes ranging from 28% to 39%
(Appendix I). There were additional trials done by adjusting the weights to “zeros” and
changing the bias to “ones”. The average classification accuracy for all images was about
23% thus severely underfitting and resulting in high training loss; neither able to model
the training images nor able to generalize the test images.
A third limitation in this study was the presence of unnecessary features such as
eyelashes (Figure 5) and camera artifacts (Figure 6) in some of the images. The presence
of eyelashes caused the CNN algorithm to learn the unnecessary features and thus
deteriorate the classification accuracy, especially for larger image sizes (256×256 and
512×512).
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Figure 5 – Presence of eyelashes towards the bottom of the fundus image.

Figure 6 – Presence of camera artifacts (i.e. camera lens reflection) towards the top of
the fundus image
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IV. CONCLUSION
The goals of this study were to develop an algorithm to classify ultra-widefield
fundus images into one of the 3 major classes of diabetic retinopathy, evaluate and
compare the accuracy of the classification between different areas and sizes of fundus
images, and explore the limitations of using CNN for ultra-widefield images.
Validation methods such as image normalization and transfer learning were also done
to calculate the classification accuracy and justify the algorithm that was developed
from scratch. While the results are not ideal, they demonstrate the potential for
applying deep learning algorithms to ultra-widefield images and the need for doctors
to further examine the diagnosis to account for false positives and/or misdiagnosis.
Future work in this subject would include improvements to the CNN algorithm
as more images are obtained in order to improve the classification accuracy.
Additional research would be done to determine if the file type of an image (e.g. JPEG
or TIF) impacts the classification accuracy. Also, instead of concentric circles which
mainly focus on the optic nerve, different sections of an image may be isolated/cut out
where the accuracy of different regions of the eye may be compared to see if the
classification accuracy solely relies on the optic nerve. Lastly, some pre-processing
would be done to remove artifacts such as eyelashes from the images to reduce the
number of features to be learned by the CNN algorithm; only if the flexibility is
available to do so i.e. large amount of data available where removal of some images
will not drastically impact the classification accuracy.
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APPENDIX I – Classification Data
A. Balanced classes

Image
size

Trials
1
2
3
4
5

32*32

Avg. (%)
1
2
3
4
5

64*64

Avg. (%)
1
2
3
4
5

128*128

Avg. (%)
1
2
3
4
5

256*256

Avg. (%)
1
2
3
4
5

512*512

Avg. (%)

Training
Accuracy
Test Accuracy
0.5439
0.4000
0.6667
0.6000
0.5995
0.6000
0.5789
0.6000
0.6140
0.4000
60.06
52.000
0.8421
0.4000
0.6140
0.4000
0.7719
0.2000
0.6140
0.4000
0.8421
0.4000
73.682
36.000
1
0.2759
0.7018
0.2000
0.7719
0.6000
0.7576
0.4000
0.9394
0.4828
83.414
39.174
0.8485
0.3103
0.6061
0.3793
0.9394
0.1724
0.6970
0.2069
0.9394
0.3448
80.608
28.274
0.8788
0.2414
0.9091
0.3103
0.8596
0.6000
0.6667
0.8000
0.8741
0.6333
83.766
51.7
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B. Unbalanced classes

Trials

Image
size

Training
Test
Accuracy
Accuracy
1
0.9038
0.6000
2
0.9615
0.7000
3 32*32
0.9038
0.4000
4
0.9423
0.3000
5
0.9230
0.5000
Avg. (%)
92.692
50.000
1
1.0000
0.4000
2
0.9807
0.5000
64*64
3
0.9807
0.6000
4
0.9615
0.5000
5
0.9423
0.4000
Avg. (%)
97.308
48.000
1
0.9038
0.6000
2
0.9615
0.5000
3 128*128
1.0000
0.4000
4
0.9807
0.5000
5
1.0000
0.6000
Avg. (%)
96.923
52.000
1
0.4615
0.5000
2
0.4615
0.5000
3 256*256
0.4615
0.5000
4
0.4615
0.5000
5
0.4615
0.5000
Avg. (%)
46.153
50.000
1
0.4807
0.5000
2
0.4615
0.5000
3 512*512
0.4615
0.5000
4
0.4615
0.5000
5
0.4615
0.5000
Avg. (%)
46.538
50.000
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APPENDIX II – Confusion Matrices
Far right column = precision, false discovery rate
Bottom row = sensitivity, miss rate
Bottom right corner = overall accuracy of current trial, overall inaccuracy of current trial

32×32
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64×64

25

128×128

26

256×256

27

512×512
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APPENDIX III – Probability Data
Red = incorrectly predicted

32×32
Patient
10001418 OS
10022953 OS
10029705-20180416@112408-L4
10029705-20180416@112408-R3
10041101 OD
10041101 OS
10046318 OS
10055620 OD
10055620 OS
10065949 OS
10068165 OD
10075046 OD
10075046 OS
10077406 OD
10077406 OS
10084968 OS
10086708 OS
10117924-20180220@102014-L4
10145754-20180415@105849-L2
10145754-20180415@105849-R1
10148705-20180425@100700-R3
10149811-20180225@090046-R1
10158969-20180506@090506-R1
10001091 OD
10001091 OS
10000464 OS
10000484 OD
10001418 OD
10004898 OS
10008285 OS
10013404 OD
10018169 OD
10022953 OD
10022979-20180213@155058-R1
10025329 OD

Type
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
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P (Abnormal)
P(Normal)
[32*32]
[32*32]
0.99998534
1.47E-05
2.43E-07
0.99999976
0.99998879
1.12E-05
0.13589142
0.86410856
0.005335684
0.99466431
3.72E-08
1
0.14558524
0.85441476
0.99221849
0.007781468
0.00250658
0.99749339
0.0087861
0.99121398
0.040095784
0.95990425
0.80176336
0.19823663
0.80258894
0.19741113
0.66958404
0.33041599
0.99926466
0.000735337
0.16454743
0.83545256
6.59E-10
1
0.79679787
0.20320213
0.99968874
0.000311262
0.99999964
3.16E-07
0.9999944
5.65E-06
0.99999905
9.38E-07
0.99999976
2.90E-07
0.38385868
0.61614132
0.23049685
0.76950318
2.74E-09
1
0.9986406
0.001359399
0.99864513
0.001354832
4.69E-15
1
0.73723733
0.26276267
0.96721429
0.032785717
0.96985573
0.03014431
0.026244124
0.9737559
0.99999571
4.26E-06
0.99999142
8.55E-06

10028832 OD
10028832 OS
10037058 OD
10037058 OS
10041971 OD
10041971 OS
10047851
10047851 OD
10051334 OD
10051334 OS
10059609-20180325@094033-L3
10065949 OD
10068165 OS
10072783-20180121@092503-L2
10075925 OD
10081192 OS
10084968 OD
10086708 OD
10088791 OD
10088791 OS
10093928 OS
10117924-20180220@102014-R2
10131726-20180319@085722-L3
10131726-20180319@085722-R2
10158969-20180506@090506-L2
10166525-20180402@083736-L4
10167812-20180424@134719-L2
# of Incorrect Classification

mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate

0.99961448
3.78E-06
0.44739011
0.1597831
0.048188951
5.42E-10
0.5488714
0.99706465
8.39E-06
0.018040443
0.090828925
0.99982738
1.01E-05
0.97144598
0.99999118
8.48E-06
0.01174185
0.000257731
1
1.82E-05
1.98E-07
0.99999177
0.007010281
0.99999964
0.99999547
0.8872788
0.05154828
16

0.000385448
0.99999619
0.55260986
0.84021693
0.95181108
1
0.45112863
0.002935403
0.99999166
0.98195964
0.9091711
0.000172549
0.99998987
0.028554037
8.78E-06
0.99999154
0.98825818
0.99974221
2.72E-23
0.99998188
0.99999976
8.24E-06
0.99298966
3.62E-07
4.52E-06
0.11272123
0.94845176
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64×64
Patient
10001418 OS
10022953 OS
10029705-20180416@112408-L4
10029705-20180416@112408-R3
10041101 OD
10041101 OS
10046318 OS
10055620 OD
10055620 OS
10065949 OS

Type
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
30

P (Abnormal)
[64*64]
1
1
1
0.99998713
1
1
1
1
1
0.99999964

P(Normal)
[64*64]
1.64E-09
8.43E-10
8.60E-09
1.29E-05
8.74E-11
1.68E-32
1.55E-21
1.93E-20
2.76E-22
3.26E-07

10068165 OD
10075046 OD
10075046 OS
10077406 OD
10077406 OS
10084968 OS
10086708 OS
10117924-20180220@102014-L4
10145754-20180415@105849-L2
10145754-20180415@105849-R1
10148705-20180425@100700-R3
10149811-20180225@090046-R1
10158969-20180506@090506-R1
10001091 OD
10001091 OS
10000464 OS
10000484 OD
10001418 OD
10004898 OS
10008285 OS
10013404 OD
10018169 OD
10022953 OD
10022979-20180213@155058-R1
10025329 OD
10028832 OD
10028832 OS
10037058 OD
10037058 OS
10041971 OD
10041971 OS
10047851
10047851 OD
10051334 OD
10051334 OS
10059609-20180325@094033-L3
10065949 OD
10068165 OS
10072783-20180121@092503-L2
10075925 OD
10081192 OS
10084968 OD
10086708 OD

abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
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0.99998391
0.99999857
1
1
0.99997497
1
1
0.99986422
0.99998403
1
1.85839E-15
1
0.99999356
1
1
1.58362E-24
1.956E-08
5.52701E-09
1.45156E-40
0.06106123
1.74044E-10
2.02048E-09
1.57295E-14
1.11E-06
4.45E-11
1.11E-06
2.92E-06
1.01E-12
1.00E+00
9.82E-01
1.79E-08
2.03E-10
4.06E-09
1.91E-23
3.85E-06
1.00E+00
8.95E-06
1.65E-05
1.07E-05
1.13E-08
2.30E-11
4.49E-13
1.62E-11

1.62E-05
1.49E-06
4.30E-18
1.64E-12
2.51E-05
2.28E-14
2.85E-15
1.36E-04
1.60E-05
8.69E-10
1.00E+00
6.47E-14
6.40E-06
8.70E-14
4.15E-21
1.00E+00
1.00E+00
1.00E+00
1.00E+00
0.9389388
1
1
1
0.99999893
1
0.99999893
0.99999714
1
1.16596E-11
0.017991316
1
1
1
1
0.99999619
3.93148E-06
0.99999106
0.99998355
0.99998927
1
1
1
1

10088791 OD
10088791 OS
10093928 OS
10117924-20180220@102014-R2
10131726-20180319@085722-L3
10131726-20180319@085722-R2
10158969-20180506@090506-L2
10166525-20180402@083736-L4
10167812-20180424@134719-L2
# of Incorrect Classification

mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate

2.49E-05
0.00E+00
4.34E-07
5.35E-11
4.32E-07
2.71E-11
2.51E-05
1.07E-05
1.01E-07
2.00E+00

0.99997509
1
0.99999952
1
0.99999952
1
0.99997485
0.99998927
0.99999988
0

128×128
Patient
10001418 OS
10022953 OS
10029705-20180416@112408-L4
10029705-20180416@112408-R3
10041101 OD
10041101 OS
10046318 OS
10055620 OD
10055620 OS
10065949 OS
10068165 OD
10075046 OD
10075046 OS
10077406 OD
10077406 OS
10084968 OS
10086708 OS
10117924-20180220@102014-L4
10145754-20180415@105849-L2
10145754-20180415@105849-R1
10148705-20180425@100700-R3
10149811-20180225@090046-R1
10158969-20180506@090506-R1
10001091 OD
10001091 OS
10000464 OS
10000484 OD

P (Abnormal)
P(Normal)
Type
[128*128]
[128*128]
abnormal
0.99999952
4.87E-07
abnormal
0.99995208
4.79E-05
abnormal
0.99989486
1.05E-04
abnormal
0.99989188
0.000108118
abnormal
0.99984419
0.000155748
abnormal
1
6.96896E-11
abnormal
0.99984348
1.56E-04
abnormal
1
8.19795E-10
abnormal
0.9999969
3.10E-06
abnormal
0.99955744
0.000442587
abnormal
0.99990392
9.60951E-05
abnormal
0.99993837
6.16E-05
abnormal
0.99998069
1.92567E-05
abnormal
0.9999969
3.14E-06
abnormal
0.99981743
0.000182557
abnormal
0.99996579
3.43E-05
abnormal
0.99994266
5.73716E-05
abnormal
0.99999535
4.61176E-06
abnormal
0.9999938
6.17E-06
abnormal
0.9999516
4.84E-05
abnormal
0.9998908
0.000109201
abnormal
0.99998224
1.77666E-05
abnormal
0.99998629
1.37E-05
abnormal
0.99988723
1.13E-04
abnormal
0.99999547
4.55215E-06
mild/moderate
4.67553E-06
0.99999535
mild/moderate
0.000164147
1.00E+00
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10001418 OD
10004898 OS
10008285 OS
10013404 OD
10018169 OD
10022953 OD
10022979-20180213@155058-R1
10025329 OD
10028832 OD
10028832 OS
10037058 OD
10037058 OS
10041971 OD
10041971 OS
10047851
10047851 OD
10051334 OD
10051334 OS
10059609-20180325@094033-L3
10065949 OD
10068165 OS
10072783-20180121@092503-L2
10075925 OD
10081192 OS
10084968 OD
10086708 OD
10088791 OD
10088791 OS
10093928 OS
10117924-20180220@102014-R2
10131726-20180319@085722-L3
10131726-20180319@085722-R2
10158969-20180506@090506-L2
10166525-20180402@083736-L4
10167812-20180424@134719-L2
# of Incorrect Classification

mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate

1.82634E-05
3.41719E-12
1.72229E-06
5.08921E-05
0.000141378
6.75234E-05
1.48E-04
1.44E-01
8.03106E-06
7.74E-02
2.03E-08
0.000249152
4.99E-05
8.07E-05
0.99851722
1.63E-04
4.39E-05
0.000212336
3.41E-05
1.00E+00
0.88677871
0.000187775
0.000161167
1.24959E-06
1.11E-05
6.08E-07
1.00E+00
2.88794E-05
1.25E-04
0.22493188
1.88E-04
2.67E-10
0.9999944
0.99999702
9.99E-01
7

1.00E+00
1.00E+00
0.99999833
0.9999491
0.99985862
0.99993253
0.99985194
0.8564226
0.99999201
0.92256796
1
0.99975079
0.99995017
0.9999193
0.001482814
0.99983692
0.99995601
0.99978763
0.99996591
5.6119E-05
0.11322127
0.9998123
0.99983883
0.99999881
0.99998891
0.9999994
5.53622E-09
0.99997115
0.99987519
0.7750681
0.99981159
1
5.60941E-06
3.02197E-06
0.000615534
0

256×256
Patient

P (Abnormal)
[256*256]

Type
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P(Normal)
[256*256]

10001418 OS
10022953 OS
10029705-20180416@112408-L4
10029705-20180416@112408-R3
10041101 OD
10041101 OS
10046318 OS
10055620 OD
10055620 OS
10065949 OS
10068165 OD
10075046 OD
10075046 OS
10077406 OD
10077406 OS
10084968 OS
10086708 OS
10117924-20180220@102014-L4
10145754-20180415@105849-L2
10145754-20180415@105849-R1
10148705-20180425@100700-R3
10149811-20180225@090046-R1
10158969-20180506@090506-R1
10001091 OD
10001091 OS
10000464 OS
10000484 OD
10001418 OD
10004898 OS
10008285 OS
10013404 OD
10018169 OD
10022953 OD
10022979-20180213@155058-R1
10025329 OD
10028832 OD
10028832 OS
10037058 OD
10037058 OS
10041971 OD
10041971 OS
10047851
10047851 OD

abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
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1
0.99997783
0.99998868
0.99999261
0.99998462
1
0.99999988
1
0.99998379
0.99996638
0.99999881
0.99996507
0.99999797
0.99999964
0.99999583
0.99999988
1
1
1
1
0.99994671
0.99999869
0.9999795
0.99997497
1
1.80009E-07
0.9988721
9.05139E-09
5.21877E-11
0.58756328
9.22898E-05
0.99998701
1.32348E-05
2.89E-05
5.43E-09
0.028293183
9.00074E-09
3.18E-14
6.41E-15
7.89E-06
2.33375E-07
7.12E-03
3.11E-05

9.18E-11
2.22E-05
1.14E-05
7.3702E-06
1.53752E-05
1.09164E-08
9.78637E-08
2.52E-11
1.63E-05
3.36E-05
1.25081E-06
3.49861E-05
2.01E-06
3.7115E-07
4.12848E-06
1.14369E-07
3.93208E-10
3.17E-13
2.96E-08
4.2894E-15
5.32E-05
1.30E-06
2.05E-05
2.51E-05
9.43E-15
1.00E+00
0.001127839
1.00E+00
1.00E+00
0.41243672
0.99990773
1.29961E-05
0.99998677
0.99997103
1
0.97170681
1
1
1
0.99999213
0.99999976
0.99288416
0.99996889

10051334 OD
10051334 OS
10059609-20180325@094033-L3
10065949 OD
10068165 OS
10072783-20180121@092503-L2
10075925 OD
10081192 OS
10084968 OD
10086708 OD
10088791 OD
10088791 OS
10093928 OS
10117924-20180220@102014-R2
10131726-20180319@085722-L3
10131726-20180319@085722-R2
10158969-20180506@090506-L2
10166525-20180402@083736-L4
10167812-20180424@134719-L2
# of Incorrect Classification

mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate

8.69E-06
2.20107E-09
1.88E-10
4.30446E-05
0.99974483
4.13E-05
9.99E-01
3.14926E-05
3.49794E-13
1.06E-06
1.19E-21
9.07903E-06
9.8197E-07
0.99951839
9.93E-10
2.40E-18
9.26337E-06
3.21697E-05
9.34E-06
6

0.9999913
1
1
0.99995697
0.000255199
0.99995875
0.000701777
0.99996853
1.00E+00
0.99999893
1
0.99999094
0.99999905
0.000481647
1
1
0.9999907
0.99996781
0.9999907
0

512×512
Patient
10001418 OS
10022953 OS
10029705-20180416@112408-L4
10029705-20180416@112408-R3
10041101 OD
10041101 OS
10046318 OS
10055620 OD
10055620 OS
10065949 OS
10068165 OD
10075046 OD
10075046 OS
10077406 OD
10077406 OS
10084968 OS

Type
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
35

P (Abnormal)
P(Normal)
[512*512]
[512*512]
0.99936146
0.000638496
0.9960413
0.003958674
0.99952638
4.74E-04
0.99940002
6.00E-04
0.97922426
0.020775726
0.98724443
0.01275562
0.92326951
0.07673049
0.9999845
1.55044E-05
0.9982987
1.70E-03
0.003065838
0.99693418
0.97903001
0.020969966
0.96919304
0.030806985
0.034994565
0.96500546
0.96866268
0.031337354
1.77919E-07
0.99999988
0.9262225
0.073777564

10086708 OS
10117924-20180220@102014-L4
10145754-20180415@105849-L2
10145754-20180415@105849-R1
10148705-20180425@100700-R3
10149811-20180225@090046-R1
10158969-20180506@090506-R1
10001091 OD
10001091 OS
10000464 OS
10000484 OD
10001418 OD
10004898 OS
10008285 OS
10013404 OD
10018169 OD
10022953 OD
10022979-20180213@155058-R1
10025329 OD
10028832 OD
10028832 OS
10037058 OD
10037058 OS
10041971 OD
10041971 OS
10047851
10047851 OD
10051334 OD
10051334 OS
10059609-20180325@094033-L3
10065949 OD
10068165 OS
10072783-20180121@092503-L2
10075925 OD
10081192 OS
10084968 OD
10086708 OD
10088791 OD
10088791 OS
10093928 OS
10117924-20180220@102014-R2
10131726-20180319@085722-L3
10131726-20180319@085722-R2

abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
abnormal
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
mild/moderate
36

0.004060022
0.999982
0.99996924
0.99999881
0.99959844
0.97366387
0.99999619
0.96762341
0.99683553
6.08433E-06
0.01140972
0.084231965
0.000502195
0.005196332
0.15164208
0.000914671
0.046061426
6.56536E-06
2.68299E-08
1.29917E-05
0.001329623
6.37248E-08
4.54236E-09
0.72162044
0.000409728
0.027813982
0.062140908
0.16369528
0.001955796
1.27724E-08
0.53620446
0.001630107
0.004932033
0.10453955
0.010845487
0.33051535
0.000114546
0.68852872
7.09177E-07
0.001435881
0.000862961
0.004823742
0.000321771

0.99593997
1.7998E-05
3.07769E-05
1.21834E-06
0.00040161
0.026336132
3.78E-06
0.032376532
3.16E-03
0.99999392
0.9885903
0.91576803
0.99949777
0.99480361
0.84835792
0.99908531
0.9539386
0.99999344
1
0.99998701
0.99867034
0.99999988
1
0.27837956
0.99959034
0.97218597
0.93785918
0.83630472
0.99804413
1
0.46379557
0.99836987
0.99506795
0.89546043
0.98915452
0.66948467
0.99988544
0.31147122
0.99999928
0.99856418
0.9991371
0.9951762
0.99967825

10158969-20180506@090506-L2
10166525-20180402@083736-L4
10167812-20180424@134719-L2
# of Incorrect Classification

mild/moderate
mild/moderate
mild/moderate

37

0.091181904
0.11425235
0.027037384
2

0.90881807
0.88574767
0.97296256
4
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